Ikarian Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Ikarian Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-22,300	Closed	-$2.07M	–	219
2021 Q4	$2.07M	Sell	22,300 -126,400	-85%	-$8.33M	0.31%	61
2021 Q3	$8.85M	Sell	148,700 -1,300	-0.9%	-$76.8K	0.62%	45
2021 Q2	$10.2M	Hold	150,000	–	–	0.83%	33
2021 Q1	$10.4M	Buy	150,000 +107,500	+253%	+$8.27M	0.35%	65
2020 Q4	$3.27M	Sell	42,500 -217,500	-84%	-$16.3M	0.14%	122
2020 Q3	$19.4M	Buy	+260,000	New	+$17.3M	1.41%	17

Ikarian Capital's ARNA Position: Q1 2022 in Review

Ikarian Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 2,161 shares — an estimated $200K sold.

Ikarian Capital first reported a position in ARNA in Q2 2020 and held it in 4 quarters. The position peaked at $373K in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Ikarian Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Ikarian Capital sold 2,161 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $200K.
Ikarian Capital first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 4 quarters.
Ikarian Capital's Arena Pharmaceuticals Inc position peaked at $373K in Q3 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Ikarian Capital's 13F filing for Q1 2022, filed 13 May 2022.